secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0001628280-24-042724
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex auditor Marcum resigns effective Oct 31 due to conflict from CBIZ merger
--------------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor effective Oct 31, 2024, citing independence concerns from its impending merger with CBIZ Inc.
- CBIZ provides HR consulting and health insurance brokerage services to ChromaDex, creating a conflict under independence rules.
- Marcum's audit reports for fiscal years 2022 and 2023 contained no adverse opinions or qualifications.
- No disagreements or reportable events occurred during the relevant periods; Board and Audit Committee were not involved in the resignation decision.
- Company has not yet named a replacement auditor; Marcum's letter to SEC filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024042724/0001628280-24-042724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024042724/cdxc-20241008.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-042724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer